Maprotiline (Ludiomil): How This Tetracyclic Antidepressant Works, Dosing, and When Telehealth Is Enough

Last updated: August 23, 2026

Maprotiline is a tetracyclic antidepressant used for depressive illness, including dysthymic disorder and major depressive disorder, and for anxiety that rides along with depression. Tablets come as generic maprotiline hydrochloride. The historic brand Ludiomil is discontinued. Maprotiline is not a controlled substance. It is not approved for children.

This guide covers what maprotiline treats, how outpatient dosing usually starts, why seizure risk shapes titration, common and serious side effects, and which parts of care a telehealth visit can handle. It is educational, not a diagnosis or a promise that any plan will pay for a specific medicine.

See if you may qualify for online depression care →

What is maprotiline?

According to MedlinePlus (revised May 15, 2017), maprotiline treats depression, bipolar disorder, and anxiety. It is a tetracyclic antidepressant. It increases certain natural substances in the brain that help maintain mental balance. Another historic brand name is Ludiomil, which is no longer marketed; generics may still be available.

The DailyMed maprotiline hydrochloride tablet label (Mylan; Medication Guide revised December 2014) describes film-coated tablets of 25 mg, 50 mg, and 75 mg. Chemical name: N-methyl-9,10-ethanoanthracene-9(10H)-propylamine hydrochloride. Molecular weight 313.87. It is not a monoamine oxidase inhibitor. The postulated action is blockade of norepinephrine reuptake at nerve endings, which may explain antidepressant and anxiolytic effects. Mean time to peak is 12 hours. Average elimination half-life is 51 hours. DEA schedule: none (human prescription drug; not listed as a controlled substance on the label).

StatPearls on antidepressants lists maprotiline with other older agents such as protriptyline and amoxapine, separate from SSRIs, SNRIs, and MAOIs.

What does maprotiline treat?

DailyMed indications: depressive illness in patients with depressive neurosis (dysthymic disorder) and manic-depressive illness, depressed type (major depressive disorder). The label also states maprotiline is effective for relief of anxiety associated with depression.

MedlinePlus lists depression, bipolar disorder, and anxiety. DailyMed is more specific: maprotiline is not approved for bipolar depression. Before starting any antidepressant, the prescriber should screen for bipolar risk, including family history of suicide, bipolar disorder, and depression, because an antidepressant alone can flip some people into mania or a mixed episode.

Providers sometimes use older tetracyclics off-label. Off-label use needs a clear clinical reason and a discussion of alternatives that may have a better safety profile.

How do you take maprotiline?

MedlinePlus: tablets one to three times a day, with or without food, at about the same times. Full benefit may take a few weeks or longer. Do not stop without talking to the prescriber; the dose is usually lowered gradually.

DailyMed dosing:

• Outpatients with mild to moderate depression: suggested start 75 mg daily. Some people, especially older adults, start at 25 mg daily.
• Hold the initial dose for 2 weeks because of the long half-life, then raise in 25 mg steps as needed and tolerated.
• Most outpatients: maximum 150 mg daily. Do not go higher except in the most severely depressed people, and then only gradually to a maximum of 225 mg.
• More severely depressed, hospitalized patients: start 100 mg to 150 mg daily; most respond at 150 mg; some need up to 225 mg. Do not exceed 225 mg daily.
• Age over 60: lower doses. Maintenance of 50 mg to 75 mg daily is often enough for older adults who do not tolerate more.
• Long-term maintenance: lowest effective level, often 75 mg to 150 mg daily, then adjust to response.

DailyMed seizure-risk steps: start low, keep the first dose for 2 weeks, raise slowly, and stay at the lowest effective maintenance dose. Rapid titration, doses above the recommended range, phenothiazines, and rapid benzodiazepine tapers raise seizure risk. Direct reports of seizures are less than 1/10 of 1%.

Missed dose (MedlinePlus): take it when you remember unless the next dose is near. Do not double up.

Browse conditions and next steps →

What side effects should you watch for?

DailyMed rates common effects: dry mouth 22%, drowsiness 16%, dizziness 8%, constipation 6%, nervousness 6%, blurred vision 4%, weakness/fatigue 4%, headache 4%, tremor 3%, anxiety 3%, insomnia 2%, agitation 2%, nausea 2%.

MedlinePlus also lists nightmares, sun sensitivity, appetite or weight change, trouble urinating or frequent urination, sexual changes, and sweating.

Serious effects that need urgent care:

• New or worse depression, suicidal thinking, agitation, panic, severe restlessness, or mania. Boxed warning: antidepressants raised suicidality versus placebo in short-term studies in people 24 and under. Maprotiline is not approved in pediatrics. DailyMed Table 1: under 18, 14 extra suicidality cases per 1,000 treated; ages 18 to 24, 5 extra; ages 25 to 64, 1 fewer; 65 and older, 6 fewer.
• Seizures, including in people with no prior seizure history.
• Jaw, neck, or back spasms; slow or difficult speech; shuffling walk; uncontrolled shaking.
• Fever, chills, sore throat, or flu-like symptoms (possible blood-count problem; stop and check labs if fever and sore throat appear).
• Trouble breathing or swallowing; rash; yellowing of skin or eyes; irregular heartbeat.
• Eye pain, vision change, or redness around the eye (angle-closure glaucoma risk from pupil dilation).
• Post-marketing reports include interstitial pneumonitis (sometimes with eosinophilia and raised liver enzymes), Stevens-Johnson syndrome, and toxic epidermal necrolysis.

Overdose can be fatal. DailyMed: cardiac dysrhythmias, severe hypotension, convulsions, and CNS depression including coma. QRS changes matter. Call Poison Control at 1-800-222-1222 or 911 if the person collapses, seizes, or cannot be awakened.

Who should not take maprotiline?

DailyMed contraindications:

• Hypersensitivity to maprotiline.
• Known or suspected seizure disorders.
• Concomitant MAO inhibitors. Wait at least 14 days after stopping an MAOI before starting maprotiline. MedlinePlus names isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate).
• Acute phase of myocardial infarction (not recommended).

Use extreme caution after a prior heart attack or with cardiovascular disease (conduction defects, arrhythmias, infarction, stroke, tachycardia). Caution with urinary retention, narrow-angle glaucoma, hyperthyroidism or thyroid medicine, guanethidine-type drugs, and elective surgery (stop as long as clinically feasible). Smoking may reduce effectiveness (MedlinePlus). Alcohol adds to drowsiness. Hepatic enzyme inhibitors such as cimetidine or fluoxetine may raise levels; barbiturates and phenytoin may lower them. Avoid concurrent electroshock for lack of experience.

Pregnancy Category B on the older label: animal studies at multiples of the human dose did not show fetal harm; there are no adequate well-controlled studies in pregnant women. Use only if clearly needed. Maprotiline is excreted in breast milk at concentrations close to whole blood. Exercise caution if nursing.

When is telehealth enough, and when is in-person care safer?

A video visit can review depressive symptoms, bipolar screening, current medicines (including MAOIs, phenothiazines, and benzodiazepines), seizure history, heart history, and whether maprotiline still makes sense versus a first-line SSRI or SNRI. Many people on a stable dose use telehealth for refills, side-effect checks, and taper planning.

In-person or emergency care is the safer path for new seizures, chest pain, fainting, severe agitation or mania, overdose, eye-pain with vision change, or fever with sore throat. HHS describes when telehealth fits routine follow-up and when a physical exam or emergency department is required. Klarity’s network includes 2,000+ licensed providers. Coverage varies by plan. Verify benefits before you book.

If you are in crisis, call or text 988 (Suicide and Crisis Lifeline) or go to the nearest emergency department.

Insurance, generics, and next steps

Many commercial plans may cover generic maprotiline when a prescriber documents medical necessity. Older tetracyclics often sit on a higher tier or need prior authorization because first-line antidepressants are preferred. Coverage varies by plan. This is not a guarantee that your plan will pay.

Disclaimer: Insurance coverage varies by plan and pharmacy benefit. Confirm benefits, copays, and prior authorization rules with your insurer and pharmacy before you start or switch medicine.

Check if your plan may cover online depression treatment →

Frequently asked questions

Is maprotiline the same as Ludiomil?

Ludiomil was the brand. MedlinePlus marks Ludiomil as discontinued. Generic maprotiline hydrochloride tablets (25, 50, 75 mg on the Mylan DailyMed label) are the same active ingredient when a pharmacy still stocks them.

Is maprotiline a controlled substance?

No. The DailyMed label lists it as a human prescription drug without a DEA schedule.

Why does maprotiline have a seizure warning?

Seizures have occurred, often without a prior seizure history, especially with fast titration, high doses, phenothiazines, or a rapid benzodiazepine taper. Known or suspected seizure disorders are a contraindication. The labeled ceiling is 225 mg daily.

Can a telehealth clinician prescribe maprotiline?

A licensed clinician may prescribe it after a visit if it is clinically appropriate and legal in your state. Many clinicians prefer newer antidepressants first. Maprotiline still requires the same boxed-warning monitoring as other antidepressants.

Need immediate support? If you or someone else may be in danger, call 988 or 911.